Lantheus Holdings (LNTH) Current Deferred Tax Assets (2014 - 2015)
Lantheus Holdings' (LNTH) quarterly Current Deferred Tax Assets came in at $95000.0 in Q4 2015, down 62.89% year-on-year from $256000.0 in Q4 2014, and down 62.89% on a QoQ basis from $256000.0 in Q4 2014.
Lantheus Holdings (LNTH) Current Deferred Tax Assets (2014 - 2015) Analysis & Trends
Lantheus Holdings (LNTH) has 2 years of Current Deferred Tax Assets data on file, last reported at $95000.0 in Q4 2015.
- On a quarterly basis, Current Deferred Tax Assets fell 62.89% year-over-year to $95000.0 in Q4 2015; TTM through Dec 2015 was $95000.0, a 62.89% decrease from a year earlier, with the FY2015 full-year figure at $95000.0, down 62.89% from the prior year.
- Current Deferred Tax Assets for Q4 2015 stood at $95000.0, down from $256000.0 in the prior quarter.
- Over the last five years, Current Deferred Tax Assets for LNTH reached as high as $256000.0 in Q4 2014 and fell as low as $95000.0 in Q4 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 95,000.00 |
| Dec 31, 2015 | 95,000.00 |
| Dec 31, 2014 | 256,000.00 |
| Dec 31, 2014 | 256,000.00 |